Author Topic: (ECTRIMS) Strike three for laquinimod in relapsing MS  (Read 30 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8223
  • MS diagnosed 1980
  • Location: Pacific Northwest
(ECTRIMS) Strike three for laquinimod in relapsing MS
« on: October 28, 2017, 12:07:33 pm »
A MedPage Today article (October 28) discusses laquinimod findings presented at the ECTRIMS conference, held in Paris, October 25-28, 2017.

The last paragraph indicates that laquinimod is still a possibility for primary progressive MS:

Quote
Teva had earlier announced that CONCERTO failed to meet its primary endpoint, and therefore the company would not seek approval for the drug in relapsing MS. But it still has ongoing trials and development interest in laquinimod for primary progressive MS and for Huntington's disease.

"Strike three for laquinimod in relapsing MS"
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
50 Views
Last post October 06, 2016, 06:27:48 am
by agate
0 Replies
31 Views
Last post June 03, 2017, 04:10:37 pm
by agate
0 Replies
93 Views
Last post September 23, 2017, 04:24:24 pm
by agate
0 Replies
1 Views
Last post September 10, 2019, 09:07:20 pm
by agate
0 Replies
2 Views
Last post September 21, 2019, 07:33:37 am
by agate